IRIS Accounts Production v24.2.0.383 10044395 director 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh100443952023-03-31100443952024-03-31100443952023-04-012024-03-31100443952022-03-31100443952022-04-012023-03-31100443952023-03-3110044395ns15:EnglandWales2023-04-012024-03-3110044395ns14:PoundSterling2023-04-012024-03-3110044395ns10:Director12023-04-012024-03-3110044395ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3110044395ns10:SmallEntities2023-04-012024-03-3110044395ns10:AuditExemptWithAccountantsReport2023-04-012024-03-3110044395ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3110044395ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3110044395ns10:FullAccounts2023-04-012024-03-3110044395ns10:RegisteredOffice2023-04-012024-03-3110044395ns5:CurrentFinancialInstruments2024-03-3110044395ns5:CurrentFinancialInstruments2023-03-3110044395ns5:Non-currentFinancialInstruments2024-03-3110044395ns5:Non-currentFinancialInstruments2023-03-3110044395ns5:ShareCapital2024-03-3110044395ns5:ShareCapital2023-03-3110044395ns5:RetainedEarningsAccumulatedLosses2024-03-3110044395ns5:RetainedEarningsAccumulatedLosses2023-03-3110044395ns5:ComputerEquipment2023-04-012024-03-3110044395ns5:ComputerEquipment2023-03-3110044395ns5:ComputerEquipment2024-03-3110044395ns5:ComputerEquipment2023-03-3110044395ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3110044395ns5:WithinOneYearns5:CurrentFinancialInstruments2023-03-31
REGISTERED NUMBER: 10044395 (England and Wales)











DEMORGAN MEDICAL LIMITED

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2024






DEMORGAN MEDICAL LIMITED (REGISTERED NUMBER: 10044395)






CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 March 2024




Page

Company information 1

Balance sheet 2

Notes to the financial statements 4

Chartered accountants' report 6

DEMORGAN MEDICAL LIMITED

COMPANY INFORMATION
for the year ended 31 March 2024







DIRECTOR: Dr P Morgan





REGISTERED OFFICE: Lygon House
50 London Road
Bromley
Kent
BR1 3RA





REGISTERED NUMBER: 10044395 (England and Wales)





ACCOUNTANTS: Berringers LLP
Chartered Accountants
Lygon House
50 London Road
Bromley
Kent
BR1 3RA

DEMORGAN MEDICAL LIMITED (REGISTERED NUMBER: 10044395)

BALANCE SHEET
31 March 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,213 1,516

CURRENT ASSETS
Debtors 5 14,561 57,833
Cash at bank 94,550 51,227
109,111 109,060
CREDITORS
Amounts falling due within one year 6 15,906 14,925
NET CURRENT ASSETS 93,205 94,135
TOTAL ASSETS LESS CURRENT
LIABILITIES

94,418

95,651

CREDITORS
Amounts falling due after more than one
year

7

6,600

10,200
NET ASSETS 87,818 85,451

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings 87,618 85,251
SHAREHOLDERS' FUNDS 87,818 85,451

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

DEMORGAN MEDICAL LIMITED (REGISTERED NUMBER: 10044395)

BALANCE SHEET - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of income and retained earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 27 January 2025 and were signed by:





Dr P Morgan - Director


DEMORGAN MEDICAL LIMITED (REGISTERED NUMBER: 10044395)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 March 2024

1. STATUTORY INFORMATION

DeMorgan Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 20% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 2 ) .

DEMORGAN MEDICAL LIMITED (REGISTERED NUMBER: 10044395)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 March 2024

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2023
and 31 March 2024 4,299
DEPRECIATION
At 1 April 2023 2,783
Charge for year 303
At 31 March 2024 3,086
NET BOOK VALUE
At 31 March 2024 1,213
At 31 March 2023 1,516

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 10,900 2,820
Other debtors 3,661 55,013
14,561 57,833

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Bank loans and overdrafts 3,600 3,600
Taxation and social security 11,103 10,325
Other creditors 1,203 1,000
15,906 14,925

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2024 2023
£    £   
Bank loans 6,600 10,200

CHARTERED ACCOUNTANTS' REPORT TO THE DIRECTOR
ON THE UNAUDITED FINANCIAL STATEMENTS OF
DEMORGAN MEDICAL LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance sheet. Readers are cautioned that the Income statement and certain other primary statements and the Report of the director are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of DeMorgan Medical Limited for the year ended 31 March 2024 which comprise the Statement of income and retained earnings, Balance sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the director of DeMorgan Medical Limited in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of DeMorgan Medical Limited and state those matters that we have agreed to state to the director of DeMorgan Medical Limited in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than DeMorgan Medical Limited and its director for our work or for this report.

It is your duty to ensure that DeMorgan Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of DeMorgan Medical Limited. You consider that DeMorgan Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of DeMorgan Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Berringers LLP
Chartered Accountants
Lygon House
50 London Road
Bromley
Kent
BR1 3RA


27 January 2025